aHSC transplants in France and Europe :
Pr D. Farge, Coordinator of the CRMR MATHEC, St-Louis Hospital, Fai2r, Université de Paris
Thymic function before and after aHSC transplantation during SSc
Pr G. Pugnet, Internal Medicine, Toulouse
Chronic inflammatory demyelinating neuropathies and aHSC transplantation: follow-up of the MATHEC national cohort
Dr F. Urbain, Internal Medicine, Bicêtre Hospital, Paris, Dr C. Beuvon, Internal Medicine, Poitiers
MS transplant patients in France and abroad: realities and duties – part 1: How can we work towards evidence-based medicine at national level?
Dr L. Terriou, Haematology, Lille
MS transplant patients in France and abroad: realities and duties – part 2: A neurologist answers patients’ questions before and after autograft
Dr K. Hankiewicz, Neurologue, Saint Denis
The organisation and qualification of centres: what are the prerequisites?
Dr A. Bonnin (Paris),Pharm D PhD, Clinical Haematology and Cellular Therapy, Saint Antoine Hospital, Paris
Identifying SSc molecular subtypes by their cellular signature
Pr D. Rimar, Rhumatology, Israël
IPS for autoimmune diseases : from lab to clinical application
Pr R. Burt, Immunotherapy and Autoimmune Diseases, Etats Unis
2024 Activity Report : CRMR MATHEC, 8th year
Mme P. Lansiaux, CRMR MATHEC, St-Louis, AP-HP
Practical solutions to physiotherapy needs
MmeY. Carrion, Mme A. Ndour, CRMR MATHEC, St-Louis, AP-HP
MATHEC registry: new developments
C. Charles, Internal Medicine, Montpellier, I. Munia, CRMR MATHEC, St-Louis, AP-HP
Presentation of the book « Par les patients, pour les patients »
S. Dessajan, Socio-anthropologist au CERLIS, Paris
From the laboratory to the clinic and back again: advances in the treatment of scleroderma and lupus
Pr K. Tarte, SITI ( Suivi Immunologique des Thérapeutiques Innovantes),Rennes
Bleomycin or intradermal HOCl for the study of SSc in mice?
Dr S. Joy, McGill University, Canada
Systemic scleroderma and MSC treatment: heterogeneity of SSc
Pr A. Lescoat, Internal Medicine, Rennes
Intrathecal MSC for the treatment of multiple sclerosis: from experimental model to human clinical application
Pr L. Michel, Neurologie, Rennes
Care pathway for patients with rheumatological ADR treated with CAR T Cells: MATHEC – SFGM-TC recommendations
Dr Z. Marjanovic, Hématologie, Hôpital St-Antoine, Paris
CAR T Cells in practice in the treatment of rheumatological ADRD: from selection to treatment of patients (round table)
Dr M. Nivet, Internal Medicine, Dijon ; Pr A. Lescoat, Internal Medicine, Rennes ; Pr D. Rimar, Rheumatology, Haifa ; Pr D. Farge, CRMR MATHEC, Hôpital St-Louis, Paris